Rhythm Pharmaceuticals, Inc. RYTM Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s change in AP?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported change in AP of -$5.62M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s change in AP changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s change in AP decreased by 54.6% year-over-year, from -$3.63M to -$5.62M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s change in AP?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s change in AP has grown at a 4.6% compound annual growth rate (CAGR), from $18.31M to $21.89M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.